COVID-KOSHA
Home
Help
(current)
Comment
!
Note: Language translations may be imperfect
A model anti-pandemic portal for scientists & public
;
High priority articles (R1, Most articles most likely to be relevant):
Second priority articles (R2, Moderate portion of articles likely to be relevant):
Other articles (R3, Lesser portion of articles likely to be relevant):
Articles Not Curated -
Drug Studies-in vitro
Last updated: 2023 Dec 18
Total hit(s): 1025
S.No.
PMID
Ascending order
Descending order
Title
Ascending order
Descending order
Journal Name
Ascending order
Descending order
Publish Date
Ascending order
Descending order
Impact Factor
Ascending order
Descending order
Citations
Ascending order
Descending order
1
38086763
Development of iminosugar-based glycosidase inhibitors as drug candidates for SARS-CoV-2 virus via molecular modelling and in vitro studies.
J Enzyme Inhib Med Chem
2024 Dec
8.6
1
2
38692139
Collection and transportation of SARS-CoV-2 and influenza A virus diagnostic samples: Optimizing the usage of guanidine-based chaotropic salts for enhanced biosafety and viral genome preservation.
Biochem Biophys Res Commun
2024 Jun 30
2.73
1
3
38652363
Deciphering the similarities and disparities of molecular mechanisms behind respiratory epithelium response to HCoV-229E and SARS-CoV-2 and drug repurposing, a systems biology approach.
Daru
2024 Jun
2.72
1
4
38708557
Human bronchopulmonary disposition and plasma pharmacokinetics of oral bemnifosbuvir (AT-527), an experimental guanosine nucleotide prodrug for COVID-19.
J Antimicrob Chemother
2024 May 6
4.94
1
5
38668705
Detection of Active SARS-CoV-2 3CL Protease in Infected Cells Using Activity-Based Probes with a 2,6-Dichlorobenzoyloxymethyl Ketone Reactive Warhead.
ACS Chem Biol
2024 May 17
8.5
1
6
38755091
Issue 4-Impact of air pollution on COVID-19 mortality and morbidity: An epidemiological and mechanistic review.
Pulmonology
2024 May 15
0.81
1
7
38742905
Inhibition of endocytic uptake of severe acute respiratory syndrome coronavirus 2 and endo-lysosomal acidification by diphenoxylate.
Antimicrob Agents Chemother
2024 May 14
4.68
1
8
38734638
Abrogation of ORF8-IRF3 binding interface with Carbon nanotube derivatives to rescue the host immune system against SARS-CoV-2 by using molecular screening and simulation approaches.
BMC Chem
2024 May 11
1
9
38735613
The synthesis and preliminary immunological evaluation of a dual-adjuvant SARS-CoV-2 RBD vaccine: Covalent integration of TLR7/8 and iNKT cell agonists.
Int J Biol Macromol
2024 May 10
4.94
1
10
38730068
Antiviral, anti-inflammatory and antioxidant effects of curcumin and curcuminoids in SH-SY5Y cells infected by SARS-CoV-2.
Sci Rep
2024 May 10
4.12
1
11
38643719
Molecular basis of N-glycan recognition by pradimicin a and its potential as a SARS-CoV-2 entry inhibitor.
Bioorg Med Chem
2024 May 1
6.5
1
12
38550333
Investigation of phytochemicals isolated from selected Saudi medicinal plants as natural inhibitors of SARS CoV-2 main protease: In vitro, molecular docking and simulation analysis.
Saudi Pharm J
2024 May
5.6
1
13
38552631
Micro-patterned culture of iPSC-derived alveolar and airway cells distinguishes SARS-CoV-2 variants.
Stem Cell Reports
2024 Apr 9
12.2
1
14
38632023
Epidemiology and antimicrobial susceptibility profiles of Enterobacterales causing bloodstream infections before and during COVID-19 pandemic: Results of the Study for Monitoring Antimicrobial Resistance Trends (SMART) in Taiwan, 2018-2021.
J Microbiol Immunol Infect
2024 Apr 7
2.33
1
15
38588829
Throat spray formulated with virucidal Pharmaceutical excipients as an effective early prophylactic or treatment strategy against pharyngitis post-exposure to SARS CoV-2.
Eur J Pharm Biopharm
2024 Apr 6
1
16
38576396
Antibiotics daptomycin interacts with S protein of SARS-CoV-2 to promote cell invasion of omicron (B1.1.529) pseudovirus.
Virulence
2024 Apr 5
4.81
1
17
38604076
Evaluation of the SARS-CoV-2 RNA detection reagent LAMPdirect Genelyzer KIT using nasopharyngeal swab and saliva samples.
Diagn Microbiol Infect Dis
2024 Apr 4
2.33
1
18
38575586
The metabolic footprint of Vero E6 cells highlights the key metabolic routes associated with SARS-CoV-2 infection and response to drug combinations.
Sci Rep
2024 Apr 4
4.12
1
19
38608595
In vitro pharmacokinetic behavior in lung of harringtonine, an antagonist of SARS-CoV-2 associated proteins: New insights of inhalation therapy for COVID-19.
Phytomedicine
2024 Apr 4
7.2
1
20
38684712
A phase 3 randomized controlled trial of a COVID-19 recombinant vaccine S-268019-b versus ChAdOx1 nCoV-19 in Japanese adults.
Sci Rep
2024 Apr 29
4.12
1
21
38703782
Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection study.
Lancet Microbe
2024 Apr 26
- n/a -
1
22
38677595
SARS-CoV-2 evolution has increased resistance to monoclonal antibodies and first-generation COVID-19 vaccines: Is there a future therapeutic role for soluble ACE2 receptors for COVID-19?
Antiviral Res
2024 Apr 25
4.12
1
23
38668391
SARS-CoV-2 Viral Shedding and Rapid Antigen Test Performance - Respiratory Virus Transmission Network, November 2022-May 2023.
MMWR Morb Mortal Wkly Rep
2024 Apr 25
14.4
1
24
38675980
The Dual-Targeted Fusion Inhibitor Clofazimine Binds to the S2 Segment of the SARS-CoV-2 Spike Protein.
Viruses
2024 Apr 20
3.76
1
25
38617221
Distal Protein-Protein Interactions Contribute to SARS-CoV-2 Main Protease Substrate Binding and Nirmatrelvir Resistance.
bioRxiv
2024 Apr 2
- n/a -
1